EP3773430A1 - Utilisation d'un film sec pour des applications topiques cosmetiques - Google Patents
Utilisation d'un film sec pour des applications topiques cosmetiquesInfo
- Publication number
- EP3773430A1 EP3773430A1 EP19715805.8A EP19715805A EP3773430A1 EP 3773430 A1 EP3773430 A1 EP 3773430A1 EP 19715805 A EP19715805 A EP 19715805A EP 3773430 A1 EP3773430 A1 EP 3773430A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dry
- skin
- cosmetic
- soluble film
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 72
- 230000000699 topical effect Effects 0.000 title claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 49
- 229920000642 polymer Polymers 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000012764 mineral filler Substances 0.000 claims abstract description 12
- 239000004014 plasticizer Substances 0.000 claims abstract description 12
- 230000002086 anti-sebum Effects 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims description 78
- 239000000203 mixture Substances 0.000 claims description 25
- 238000009499 grossing Methods 0.000 claims description 16
- 230000036074 healthy skin Effects 0.000 claims description 13
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 11
- 230000003020 moisturizing effect Effects 0.000 claims description 11
- -1 glycerol ethers Chemical class 0.000 claims description 10
- 208000035484 Cellulite Diseases 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 206010049752 Peau d'orange Diseases 0.000 claims description 8
- 230000003712 anti-aging effect Effects 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 230000035515 penetration Effects 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 150000002170 ethers Chemical class 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 229920002752 Konjac Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229920001218 Pullulan Polymers 0.000 claims description 2
- 239000004373 Pullulan Substances 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 159000000007 calcium salts Chemical class 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 230000001186 cumulative effect Effects 0.000 claims description 2
- 229940097362 cyclodextrins Drugs 0.000 claims description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 229910052900 illite Inorganic materials 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical group O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000252 konjac Substances 0.000 claims description 2
- 235000019823 konjac gum Nutrition 0.000 claims description 2
- 150000003893 lactate salts Chemical class 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000010445 mica Substances 0.000 claims description 2
- 229910052618 mica group Inorganic materials 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 235000019423 pullulan Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 claims 1
- 241000388430 Tara Species 0.000 claims 1
- 229920000591 gum Polymers 0.000 claims 1
- 239000011256 inorganic filler Substances 0.000 claims 1
- 229910003475 inorganic filler Inorganic materials 0.000 claims 1
- 229910052901 montmorillonite Inorganic materials 0.000 claims 1
- 229910001562 pearlite Inorganic materials 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 abstract description 9
- 210000003491 skin Anatomy 0.000 description 73
- 206010040954 Skin wrinkling Diseases 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 17
- 238000005259 measurement Methods 0.000 description 16
- 229920001542 oligosaccharide Polymers 0.000 description 13
- 235000019534 high fructose corn syrup Nutrition 0.000 description 11
- 230000037303 wrinkles Effects 0.000 description 11
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 230000007774 longterm Effects 0.000 description 7
- 210000002374 sebum Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 239000004744 fabric Substances 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 4
- 206010039792 Seborrhoea Diseases 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000036232 cellulite Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 208000008742 seborrheic dermatitis Diseases 0.000 description 3
- 240000007817 Olea europaea Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241001083912 Cotyledon orbiculata Species 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 231100000233 OECD 428 Skin Absorption: In Vitro Method Toxicity 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229940075946 dermatop Drugs 0.000 description 1
- SHFGJEQAOUMGJM-UHFFFAOYSA-N dialuminum dipotassium disodium dioxosilane iron(3+) oxocalcium oxomagnesium oxygen(2-) Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[Fe+3].[Fe+3].O=[Mg].O=[Ca].O=[Si]=O SHFGJEQAOUMGJM-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 239000005338 frosted glass Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- FNPXMHRZILFCKX-KAJVQRHHSA-N prednicarbate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O FNPXMHRZILFCKX-KAJVQRHHSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to the use for cosmetic applications of a particular dry film with or without a cosmetic active ingredient. It also relates to a cosmetic method of non-therapeutic treatment of the skin which consists in applying to the healthy skin said dry film under certain conditions.
- An object of the invention is therefore to provide a dry cosmetic film capable of acting on the healthy skin and when it contains a cosmetic active ingredient to promote the penetration in large amounts and / or faster of said active ingredient in the skin , ie to improve the cutaneous bioavailability of said active ingredient.
- the invention therefore proposes another solution, namely the use of a particular dry film for cosmetic topical applications.
- this dry film makes it very advantageous, on the one hand, to obtain cosmetic effects when it is applied to the skin without an active ingredient and, on the other hand, when it contains active ingredients, to promote considerably the bioavailability of these in the skin and therefore their functionality in the skin.
- the subject of the invention is the use of a dry film exhibiting a water activity of less than 0.6, for a topical cosmetic treatment of healthy (that is to say non-therapeutic) skin, which dry film comprising:
- At least one mineral filler said mineral filler representing at least 5% by weight of the dry film
- At least one polymer of natural origin said polymer representing at least 15% by weight of the dry film
- At least one plasticizer said plasticizer representing at least 20% by weight of the dry film
- At least one surfactant said surfactant representing at least 0.1% by weight of the dry film.
- the particular dry film useful according to the invention may comprise other constituents and in particular at least one active ingredient.
- the subject of the invention is also a cosmetic method for the treatment or therapeutic treatment of the skin, which consists in applying at least once a dry film exhibiting a water activity of less than 0.6 on the skin for between 5 and 30 minutes.
- said dry film comprising:
- At least one mineral filler said mineral filler representing at least 5% by weight of the dry film
- At least one polymer of natural origin said polymer representing at least 15% by weight of the dry film
- At least one plasticizer said plasticizer representing at least 20% by weight of the dry film
- At least one surfactant representing at least 0.1% by weight dry film weight
- polymer of natural origin or “biopolymer” means polymers derived from natural raw materials, as opposed to synthetic polymers, which are obtained by chemical synthesis.
- film is intended to mean a cosmetic product which is applied momentarily to the skin and which is removed after a certain time of application, having a cosmetic or dermocosmetic effect. It can for example be a mask for the face.
- cosmetic active ingredient or “cosmetic active ingredient” or “active ingredient” or “active ingredient” means one or more molecules having cosmetic efficacy when it is applied to the skin.
- non-therapeutic cosmetic treatment of the skin within the meaning of the invention means a cosmetic treatment on a healthy skin.
- smoothing cosmetic treatment within the meaning of the invention is meant a cosmetic treatment for relieving itchy skin, skin discomfort and skin irritation. It is therefore a comfort treatment and not for the purpose of treating a skin disease by restoring health.
- water content of the dry film is meant the amount of liquid water contained in the film (ratio of the weight of water to the total weight of the film).
- the invention relates to the use of a dry and soluble film having a water activity of less than 0.6, for a non-therapeutic cosmetic topical treatment of a healthy skin, which dry film comprising: At least one mineral filler, and
- At least one polymer of natural origin At least one polymer of natural origin, and
- At least one plasticizer At least one plasticizer, and
- At least one surfactant At least one surfactant.
- the invention relates to the use of such a dry and soluble film for one or more of the following specific cosmetic applications:
- the use according to the invention concerns at least one use for a moisturizing and / or anti-sebum effect and optionally one or more other specific cosmetic applications, in particular chosen from those mentioned above.
- the dry and soluble film useful according to the invention can have these cosmetic effects without containing an active ingredient, but these effects can be reinforced by the presence of one or more cosmetic active ingredients in the film.
- the specific constitution and characteristics of the dry film make it possible to promote the transdermal bioavailability of the active ingredients in a significant amount. It has, due to its constitution and its characteristic of dry film with a water activity lower than 0.6, special mechanical properties, which assure him resistance and flexibility for an optimal application on the skin and a very use easy and enjoyable.
- the film has a water activity of less than 0.6.
- This parameter well known to those skilled in the art allows to know the availability of water in the material. It can be measured using a device named AWmeter such as an AWmeter LabSift-aw type. The value is without unit, it is between 0 and 1.
- the water content of the dry and soluble film whose cosmetic use is the subject of the invention is less than 6% by weight of the total weight of the dry film.
- This parameter is different from the activity of water and is measured by successive weighings before and after drying in the oven.
- the solubility of the dry film is determined as follows: a round of film 3.5 cm in diameter is deposited in 20 ml of water at 25 ° C. with stirring of 200 rpm. A film is considered soluble within the meaning of the invention when it is solubilized completely in less than one hour.
- the film is preferentially:
- the dry film advantageously when applied to the skin:
- the invention therefore also relates to the use on the skin of a film to promote the transdermal penetration of the active principle (s) active (s) cosmetic (s) present in the film.
- the film according to the invention allows a greater bioavailability in the skin of the active ingredients it contains, compared to that obtained with the cosmetic or dermocosmetic masks of the prior art.
- dry and soluble film according to the invention can also be used in particular for:
- the dry and soluble film used according to the invention comprises from 0.5 to 25% of at least one cosmetic active ingredient.
- the cosmetic active principle (s) may be chosen from known or unknown cosmetic active principles, and in particular it comprises at least one active principle chosen from moisturizing and / or smoothing and / or improving the radiance of the complexion and / / or anti-sebum and / or anti-wrinkle and / or anti-aging and / or depigmenting and / or concealer and / or anti-puffiness under the eyes and / or anti-skin imperfections and / or soothing and / or anti -celluliteux.
- the use can be for an immediate effect and possibly unique, or for a cure effect.
- the dry and soluble film whose cosmetic use is the subject of the invention comprises at least one mineral filler which is chosen from kaolin, talc, sodium montmorillonite or calcium, mica, illite, perlite, diatomaceous earth, potassium, sodium or calcium salts, and mixtures thereof.
- the mineral filler may represent at least 5% by weight of the dry film, preferably between 5% and 75%. These mineral fillers are not in the form of nanoparticles, and have not been chemically modified.
- the polymer (s) of natural origin is (are) chosen from polymers extracted from plants or from algae or microorganisms. It is preferentially of polysaccharide of natural origin, and preferentially the polymer (s) of natural origin present in the dry film useful according to the invention are chosen from pullulan, cellulose, chitosan, gum arabic, guar gum, tara gum gellan gum, konjac gum, xanthan gum, pectin, maltodextrin, cyclodextrins, polysaccharides, carrageenans, and mixtures thereof.
- the content of polymers of natural origin in the dry film is preferably greater than 15% by weight of the dry film, and preferably between 15 to 75% by weight of the dry film.
- the polymers of natural origin are soluble in water.
- the dry and soluble film as described above also comprises other constituents and in particular:
- At least one surfactant compatible with a topical cosmetic application which represents less than 10% by weight of dry matter of the film, preferably less than 2% by weight of dry matter of the film and
- At least one plasticizer compatible with a topical cosmetic application preferably chosen from urea, glycerol, glycerol esters and ethers, monosaccharides, sorbitol, sucrose, amino acids, glycols such as butylene glycol or propylene glycol, fatty alcohols, lactate salts, esters and ethers and mixtures thereof, the plasticizer (s) being (s) present (s) between 20 and 80% by weight relative to the weight of dry matter of the movie.
- the plasticizer is soluble in water.
- the dry and soluble film does not comprise hydrophobic polymers, polyisobutylenes type, vinyl ether polymer, polysiloxanes
- the invention also specifically targets a cosmetic process for the non-therapeutic treatment of the skin, which consists in applying at least once a useful film according to the invention.
- invention on the skin, for between 5 and 30 minutes, preferentially for a moisturizing and / or smoothing effect and / or improving the radiance of the complexion and / or anti-sebum and / or anti-wrinkle and / or anti-aging and / or depigmenting and / or concealer and / or anti-puffiness under the eyes and / or anti-skin imperfections and / or soothing and / or anti-cellulite.
- the skin is moistened before application of the film.
- a particularly suitable application time is between 10 and 30 minutes.
- the film can be applied to the face for use as a mask but also on any other part of the body such as areas with cellulite or imperfections.
- the film must therefore have mechanical properties allowing it to marry any form of the face or body. It must be flexible to apply easily on the face or body. It must be resistant to not tear during handling during the pose on the skin. It must be elastic to adapt to all forms (hollow, relief) of the skin.
- a cure effect it is best to apply at least twice a week on the skin the film.
- This example presents different films that are either without active ingredient or with one or two active ingredients.
- Film A does not contain any active ingredient.
- Film B contains an active ingredient, di and tripeptides.
- the compositions of the films are presented below:
- This example presents different films that are either without active ingredient or with one or two active ingredients.
- Film A does not contain any active ingredient.
- Film B contains an active ingredient, glucose-fructose oligosaccharides and galactoxylans.
- Film C contains an active ingredient, peptides
- Film D contains an active ingredient, sulfated polygalactomannans and galactans
- compositions of the films are presented below:
- This film contains an active ingredient, glucose-fructose oligosaccharides. Its composition is presented below:
- This film contains an active ingredient, glucose-fructose oligosaccharides. Its composition is presented below:
- This film contains an active ingredient, glucose-fructose oligosaccharides. Its composition is presented below:
- This example presents different films that are either without active ingredient or with one or two active ingredients.
- Film A does not contain any active ingredient.
- Film B contains an active ingredient, di and tripeptides
- Film C contains an active ingredient, polyphenolic acids.
- compositions of the films are presented below:
- This film contains an active ingredient, glucose-fructose oligosaccharides. Its composition is presented below:
- the film of this example contains two active ingredients, oligosaccharides of galactoxylans and glucose-fructose. Its composition is presented below:
- This film contains two active ingredients, oligosaccharides of galactoxylans and glucose-fructose. Its composition is presented below:
- This film example contains two active ingredients, peptides and glucose-fructose oligosaccharides. Its composition is presented below:
- This example presents different films that are either without active ingredient or with one or two active ingredients.
- Film A does not contain any active ingredient.
- Film B contains two active ingredients, oligosaccharides of galactoxylans and glucose-fructose.
- Film C contains an active ingredient, glucose oligosaccharide, fructose and galacturonic acid.
- Film D contains an active ingredient, oligosaccharides of galactomannans.
- Film E contains an active ingredient, Mannan Polysaccharides.
- the compositions of the films are presented below:
- This film contains two active ingredients, oligosaccharides of galactoxylans and glucose-fructose. Its composition is presented below:
- This film does not contain any active ingredient. Its composition is presented below:
- This film does not contain any active ingredient. Its composition is presented below:
- This film does not contain any active ingredient. Its composition is presented below:
- This film example contains two active ingredients, peptides and glucose-fructose oligosaccharides. Its composition is presented below:
- This film example contains two active ingredients, polyphenols and oligofrucrosanes. Its composition is presented below:
- Young's Modulus (MPa) (Conventional Constraint) / (Relative Elongation)
- the Young's Modulus is a measure that is thus independent of the characteristics of the films. The lower the value, the more flexible the film.
- Energy is the energy needed to break the film.
- Elongation is the ability of the film to stretch without breaking.
- the films D, E and F are films corresponding to those described in FR3029103.
- Examples 1, 2, 4, 6, 10 and 11 of the present invention are all characterized by a Young's modulus lower than the films of the prior art. They are therefore more flexible. But they also all have a higher energy required for breaking than those according to the prior art. They are therefore more resistant. Finally, their elongations without rupture are higher than for the films of the prior art. They are therefore longer.
- the film containing the active whose bioavailability is studied, is deposited on the skins during 10 to 20 minutes. After 10 to 20 minutes of contact, the film is removed, the molecules present on the surface of the skin are removed. The layers of the stratum corneum of the skin are then removed and the active present in these layers is extracted and quantified, it corresponds to the content of the active ingredient in the stratum corneum.
- the assay of the active ingredient in the samples is carried out according to a method adapted to the nature of the test asset, such as, for example, by fluorometry, by chromatography, or any other analytical method adapted to the assay of the chosen active ingredient.
- results are expressed as a percentage of active ingredient present in the stratum corneum with respect to the amount of active ingredient deposited on the skin.
- the different formulas of masks of the market allow a low bioavailability of the active ingredient in the stratum corneum. There is, moreover, no variation between the different formulas, which is of mask-cream type, mask fabric + lotion or hydrogel mask.
- the functionality on the skin of different films containing or not different active ingredients, that is to say the performance in terms of cosmetic effectiveness of the films was evaluated on volunteers.
- the cosmetic evaluation of the films concerned the moisturizing or smoothing effect or improving the complexion or lightening / depigmenting or anti-seborrhoeic or anti-aging.
- the effects have also been studied immediately after the application of a single film, or in the long term after a cure of several films.
- the volunteers apply the film on the face or part of the face for 10 to 20 minutes.
- the moisturizing, smoothing, radiance, anti-seborrhea and anti-wrinkle effects were evaluated immediately after a single film to evaluate the immediate effect, and / or in the long term, after the application of 8 films distributed 28 days.
- This study consists of evaluating the immediate moisturizing effect of the film that does not contain or contains an active ingredient. Hydration rate measurements were performed at the forehead using a MoistureMeter-D ® from Delfin Technologies.
- the MoistureMeter D ® generates a high frequency electromagnetic wave that is sent by a probe to the skin.
- the reflected electromagnetic wave is recorded, thereby obtaining a dielectric constant proportional to the water content of the measured tissue.
- the higher the value of this constant the greater the water content of the fabric.
- the probe used to carry out the measurements is the XS5 probe which mainly measures the water content of the epidermis at the effective measurement depth of 0.5mm. 12 to 21 volunteers applied a film for 10 minutes on the face. The measurements were made before and after removal of the film.
- the evaluation of the anti-seborrhea effect is carried out by measuring the level of sebum on the surface of the skin. Measurements of sebum were made at the forehead before and after application of the film. Measurements were made using a MPA 580 ® handset.
- the MPA580 ® allows direct measurement of sebaceous secretion.
- the plastic film contained in a cassette is translucent and matt (type frosted glass). In contact with the sebum, this film becomes transparent according to the amount of scum located on the surface of the skin.
- the Determination of sebum is achieved by introducing the cassette head into the MPA580 ® handset. A cell then analyzes the transparency of the film. The results are displayed in pg of sebum / cm 2 of skin.
- the measurements were made before the application of the film and 10 minutes after the removal of the film.
- the various films were tested by 11 to 21 volunteers with a sebum level greater than 150.
- the evaluation of the smoothing effect was carried out by analysis of the cutaneous microrelief of the crow's feet by projection of fringes, apparatus dedicated to the 3D measurement of the cutaneous relief (Eotech).
- This system includes a measurement sensor combining a bright fringe projector and a high resolution CCD camera connected to an Optocat acquisition software (Eotech).
- a system of repositioning the volunteer's head according to the 3 axes of displacement makes it possible to find the same measurement zone at the different times of the study.
- the effect of the film is measured on a region of interest cut automatically on the original acquisition.
- the microrelief of the skin is studied by the 3D roughness parameter (Sa) which represents the arithmetic average of surface roughness.
- the software used is the OPTOCAT software, EOTECH. A decrease in these different parameters is characteristic of a smoothing of the studied surface.
- This film refines the grain of the skin
- This first study consists of evaluating the immediate effect of the film. 12 to 20 volunteers applied the film for 20 minutes on the face. Measurements were taken before and 30 minutes after the removal of the film.
- the parameter Sa characteristic of the roughness of the skin microrelief is decreased.
- the cutaneous microrelief of the volunteers is smoothed.
- the film brings an instant smoothing and refines the skin texture. b / long-term effect
- This study consists in evaluating the long-term effect of the film. 12 to 20 volunteers made 8 films in 28 days. Each film was applied for 20 minutes on the face. The measurements are made before the first film and the day after the 8th film.
- the parameter Sa characteristic of the roughness of the skin microrelief is decreased by 7.1%. Thanks to the treatment of 8 films, the cutaneous microrelief of volunteers is smoothed in a sustainable way.
- the film smoothes their skin in a lasting way and reduces skin imperfections.
- the evaluation of the radiance of the complexion was carried out blind by two experts previously trained to judge different parameters representative of the radiance of the complexion.
- the radiance of the skin is characteristic of a radiant complexion. The higher the intensity of the light hooks on the prominent areas of the face, the brighter the skin is.
- the light pink color characterizes a radiant complexion. The more the complexion is pink, the more it is perceived as fresh.
- this parameter is representative of the good-looking effect, if the olive color decreases the good-looking effect is more important.
- This film brings a sparkle
- This first study consists in evaluating the immediate effect of the film with or without active principle. 15 to 20 volunteers applied the film for 20 minutes on the face. Measurements were taken before and 30 minutes after the removal of the film.
- the film improves the good-looking effect and radiation of the skin of the volunteers.
- the film brings an immediate boost and revives the radiance of the complexion.
- This study consists in evaluating the long-term effect of the film. 15 to 20 volunteers made 8 films in 28 days. Each film was applied for 20 minutes on the face. The measurements are taken before the first film and the next day the 8th film. The results are as follows:
- the cure of 8 films has improved the good-looking effect, the radiant complexion and decrease the dull complexion of the skin of the volunteers.
- the 8-film cure brings a permanent glow to their skin and 94% of the volunteers indicate that the cure of 8 films makes their skin more homogeneous.
- Evaluation of the immediate anti-wrinkle effect was performed by analyzing the depth of the main wrinkle at the crow's feet. Standardized facial photographs were made under reproducible lighting conditions using a VISIA-CR (Canfield) system. The visualization of the initial images at the different measurement times as well as the use of a tracking film makes it possible to ensure the good repositioning of the subjects at the different times of the study.
- VISIA-CR Canfield
- the evaluation of crow's feet wrinkles was carried out according to the following recommendations: evaluation of the depth of the main wrinkle, not taking into account the number of wrinkles, not taking into account the width of the wrinkles, not taking into account account for any scars.
- the volunteers had to evaluate the stage of wrinkles of their crow's feet by observing themselves in a mirror according to the scale above. This evaluation was done before and after the film was made.
- the study consists in evaluating the immediate effect of the film for its immediate anti-wrinkle effect. 12 to 20 volunteers applied the film for 20 minutes on the face. Self-evaluations were done before and 30 minutes after the film was removed.
- the volunteers also say that the film makes the skin smoother, more hydrated, softer for 92% of the volunteers.
- the film lifts for 75% of the volunteers.
- the film reduces wrinkles around the eye and fades wrinkles and fine lines.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1870340A FR3079145B1 (fr) | 2018-03-26 | 2018-03-26 | Utilisation d'un film sec pour des applications topiques cosmetiques |
PCT/EP2019/057527 WO2019185597A1 (fr) | 2018-03-26 | 2019-03-26 | Utilisation d'un film sec pour des applications topiques cosmetiques |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3773430A1 true EP3773430A1 (fr) | 2021-02-17 |
Family
ID=62816854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19715805.8A Pending EP3773430A1 (fr) | 2018-03-26 | 2019-03-26 | Utilisation d'un film sec pour des applications topiques cosmetiques |
Country Status (7)
Country | Link |
---|---|
US (1) | US20210022966A1 (fr) |
EP (1) | EP3773430A1 (fr) |
JP (1) | JP2021518419A (fr) |
KR (1) | KR20200135807A (fr) |
CN (1) | CN111902122A (fr) |
FR (1) | FR3079145B1 (fr) |
WO (1) | WO2019185597A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3113247A1 (fr) | 2020-08-05 | 2022-02-11 | Societe Industrielle Limousine D'application Biologique | Utilisation d’une composition cosmétique pour peaux matures sous forme d’un film sec et soluble comprenant un extrait deTropaeolum majuset un extrait deLens esculenta |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2660555B2 (ja) * | 1988-08-02 | 1997-10-08 | 株式会社コーセー | フイルム状メーキヤツプ化粧料 |
DE69625549T2 (de) * | 1995-06-27 | 2003-05-15 | Kao Corp | Pflaster mit wasserlöslicher Klebeschicht |
JP3595069B2 (ja) * | 1995-06-27 | 2004-12-02 | 花王株式会社 | シート状入浴剤組成物 |
FR2737115B1 (fr) * | 1995-07-25 | 1997-08-22 | Oreal | Composition stable contenant une enzyme |
JP3486120B2 (ja) * | 1997-11-27 | 2004-01-13 | 株式会社資生堂 | パック化粧料 |
CN1134249C (zh) * | 1997-11-27 | 2004-01-14 | 株式会社资生堂 | 面膜化妆品 |
US20050080039A1 (en) * | 2003-10-14 | 2005-04-14 | Cp Kelco, U.S., Inc. | Pectin films prepared from gamma irradiated pectin |
JP5511319B2 (ja) * | 2009-11-10 | 2014-06-04 | 三栄源エフ・エフ・アイ株式会社 | 乾燥ゲルシートおよびその利用 |
AU2012312170C1 (en) * | 2011-09-21 | 2018-01-04 | Shiseido Company, Ltd. | Compositions and methods for treating conditions of compromised skin barrier function |
FR2990348B1 (fr) * | 2012-05-10 | 2016-07-01 | Lvmh Rech | Composition et procede de soin cosmetique utilisant un melange elastique |
US20140303135A1 (en) * | 2013-04-04 | 2014-10-09 | The Procter & Gamble Company | Personal Care Compositions Having Dried Zinc Pyrithione-Polymer Aggregates |
JP2015147750A (ja) * | 2014-02-07 | 2015-08-20 | 株式会社コーセー | パック化粧料 |
FR3029103B1 (fr) * | 2014-11-27 | 2018-02-16 | Societe Industrielle Limousine D'application Biologique | Pansement adhesif soluble a base de mineraux |
-
2018
- 2018-03-26 FR FR1870340A patent/FR3079145B1/fr active Active
-
2019
- 2019-03-26 WO PCT/EP2019/057527 patent/WO2019185597A1/fr unknown
- 2019-03-26 EP EP19715805.8A patent/EP3773430A1/fr active Pending
- 2019-03-26 US US17/040,143 patent/US20210022966A1/en active Pending
- 2019-03-26 JP JP2020551323A patent/JP2021518419A/ja active Pending
- 2019-03-26 CN CN201980020434.9A patent/CN111902122A/zh active Pending
- 2019-03-26 KR KR1020207028870A patent/KR20200135807A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
KR20200135807A (ko) | 2020-12-03 |
JP2021518419A (ja) | 2021-08-02 |
WO2019185597A1 (fr) | 2019-10-03 |
US20210022966A1 (en) | 2021-01-28 |
FR3079145B1 (fr) | 2020-02-28 |
CN111902122A (zh) | 2020-11-06 |
FR3079145A1 (fr) | 2019-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7013377B2 (ja) | 保湿性組成物及びその使用 | |
EP1420758B1 (fr) | Composition cosmetique a effet tenseur de la peau | |
EP3407866B1 (fr) | Agent cosmetique constitue par des galactomannanes obtenus a partir de caesalpinia spinosa et des galactanes sulfates reticules obtenus a partir de kappaphycus alvarezii | |
LU93280B1 (fr) | Composition cosmétique à base d'extraits d'Avena sativa, de Lens esculenta et de Tropaeolum majus | |
FR2990348A1 (fr) | Composition et procede de soin cosmetique utilisant un melange elastique | |
WO2015181750A1 (fr) | Utilisation cosmetique d'un polysaccharide sulfate | |
EP2655420A1 (fr) | Polymere saccharidique obtenu a partir de manihot esculenta, procede d'obtention et utilisation comme principe actif cosmetique tenseur de la peau | |
WO2019185597A1 (fr) | Utilisation d'un film sec pour des applications topiques cosmetiques | |
EP3937884A1 (fr) | Nouvelle utilisation cosmetique de spheres poreuses d'oxyde metallique | |
WO2023012440A1 (fr) | Utilisations cosmétiques contre la lumière bleue de microsphères poreuses d'oxyde métallique | |
FR3062302A1 (fr) | Nouvelle composition cosmetique comprenant de la nacre ou un extrait de nacre | |
FR3044223A1 (fr) | Composition cosmetique et utilisation | |
FR3094230A1 (fr) | Utilisation capillaire de l’association de galactomannanes obtenus a partir de caesalpinia spinosa et de galactanes sulfates reticules obtenus a partir de kappaphycus alvarezii | |
FR3097767A1 (fr) | Principe actif obtenu à partir de fleurs deNymphaea alba | |
WO2012153076A2 (fr) | Procede de traitement cosmetique de la peau en deux etapes successives | |
WO2019081859A1 (fr) | Utilisation cosmétique d'un extrait d'ivoire végétal (phytelephas sp.) | |
FR3036616A1 (fr) | Principe actif cosmetique sous forme de gel comprenant au moins une argile a structure feuilletee et des acides alpha-hydroxiques, et compositions cosmetiques le comprenant. | |
FR2947172A1 (fr) | Composition cosmetique, kit de traitement de la peau, procede pour traiter les peaux grasses, mixtes ou acneiques | |
FR2992554A1 (fr) | Procede de rajeunissement de la peau | |
FR3134969A1 (fr) | Compositions et procédé pour obtenir une couverture uniforme par des produits cosmétiques pendant et après l'application ; Quantification facile de ces produits. | |
WO2023186353A1 (fr) | Dextrines hyperbranchees pour leur utilisation topique pour la prevention ou le traitement d'au moins un symptome de l'inflammation cutanee | |
WO2022029129A1 (fr) | Utilisation d'une composition cosmetique pour peaux matures sous forme d'un film sec et soluble comprenant un extrait de tropaeolum majus et un extrait de lens esculenta | |
FR3008891A1 (fr) | Principe actif a application cutanee obtenu a partir de metschnikowia pulcherrima et utilisation cosmetique | |
FR3131838A1 (fr) | Nouvelle utilisation cosmétique de sphères poreuses à porosité fermée d’oxyde métallique | |
FR3071152A1 (fr) | Produits pour les soins cosmetiques du visage et des cheveux a effet ameliore |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201019 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |